"China believes that it has clearly established its intentions to clean up the Party and is now focusing on corporations. It is unprecedented for the government to punish the private pharmaceutical companies that were implicated in the drug briberies. Chinese authorities are tracing bribe payments back from the individuals and companies implicated in their investigations to those who paid the bribes", according to this article published on "The Metropolitan Corporate Counsel" which is written by Jeffrey Harfenist, Managing Director of UHY Advisors FLVS, Inc.

“We have seen a significant increase in law enforcement of anti-corruption laws in China and an unprecedented focus by U.S. law enforcement authorities on the activities of U.S. companies in China. As a consequence, many U.S. companies currently doing business in China are aggressively reviewing their in-country activities to ensure compliance with the FCPA, as well as local law," the article continues.

This is an important artice with lots of valuable observations by legal experts in this field and many practical suggestions and example cases. A recommended read for all executives involved with doing business in China.

For full text of the article, please click on the following link to down the PDF version.  This is only the Part I of the article, and we will make Part II available to our subscribers if and when it is available to us.

U.S. Companies Could Be Implicated As China Aggressively Prosecutes Bribe Recipients - Part I.pdf